We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Releases Guidance on Cancer Trial Endpoints
The item has been added to your shopping cart.
FDA Releases Guidance on Cancer Trial Endpoints
April 8, 2005
The FDA has released the first in a series of guidance documents that provide recommendations on clinical trial endpoints for the approval of cancer drugs and biologics.